Trial intelligence / Profile preview

PROACTIVE: Propranolol for Sedation in Mechanically Ventilated ICU Patients

NCT04467086Phase 3Completed

Sponsor
Ottawa Hospital Research Institute
Start
Jan 2021
Primary completion
Nov 2022
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of propranolol in agitation, sponsored by Ottawa Hospital Research Institute. Started Jan 2021; status: completed.

02

Drugs

propranolol
03

Conditions

agitation

Beyond the preview

Go deeper on NCT04467086.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04467086.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call